Reach Us +44-1235425476
Editor - Seza A Gulec | Florida International University | 303
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
  • World Conference on Clinical and Medical Case Reports
    Mar 16-17-2020 Hong Kong, Hong Kong
  • 5th International Conference on Clinical & Medical Case Reports
    April 16-17, 2020 Amsterdam, Netherlands

Seza A Gulec

Seza A Gulec
Seza A Gulec
Professor of Surgery
Director of Radiology, Nuclear Medicine, Surgical Oncology 
Florida International University
College Of Medicine
Miami, USA
Florida International University


Dr. Gulec received his medical degree at Ankara University College of Medicine, Ankara, Turkey. He trained in surgery in Louisiana State University Health Sciences Center in New Orleans, LA, in nuclear medicine and nuclear oncology at the Memorial Sloan-Kettering Cancer Center in New York, NY, and in surgical oncology at the John Wayne Cancer Institute in Santa Monica, CA. Dr. Gulec has started a comprehensive cancer program at the FIU/JNMC, integrating surgical and nuclear oncology. This unique model involves PET/CT-guided surgical treatment planning and radionuclide therapy of advanced cancers.

Research Interest

His research interests include Surgical and nuclear oncology, He has Authored landmark publications in lymphatic, Mapping, Sentinel node biopsy, Radioguided, Surgery, Radionuclide therapy, and molecular imaging. The main focus of Dr. Gulecs current research is molecular imaging and targeted radionuclide therapy in solid tumors. His laboratory is actively involved in the development of novel PET imaging agents, Radioimmuno, Radiopeptide and radiomicrosphere therapy strategies.



Global Speakers in the subject

Global Experts in the subject